Duration of Fecal Excretion of Clostridium Botulinum and Botulinum Neurotoxin in Patients Recovering from Infant Botulism.

Clostridium botulinum botulinum toxin detection fecal excretion infant botulism

Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 02 12 2022
revised: 06 03 2023
accepted: 25 03 2023
medline: 10 7 2023
pubmed: 3 4 2023
entrez: 2 4 2023
Statut: ppublish

Résumé

This study sought to determine duration of fecal excretion of Clostridium botulinum organisms and neurotoxin after onset of infant botulism in 66 affected infants. Median excretion was longer for type A than type B patients (organisms: 5.9 vs 3.5 weeks, toxin: 4.8 vs 1.6 weeks, respectively). Toxin excretion always ceased before organism excretion. Antibiotic therapy did not affect duration of excretion.

Identifiants

pubmed: 37004956
pii: S0022-3476(23)00223-8
doi: 10.1016/j.jpeds.2023.113396
pii:
doi:

Substances chimiques

Botulinum Toxins EC 3.4.24.69

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

113396

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Haydee A Dabritz (HA)

Infant Botulism Treatment and Prevention Program, Infectious Diseases Laboratories Division, Center for Laboratory Sciences, California Department of Public Health, Richmond, CA.

Jessica R Payne (JR)

Infant Botulism Treatment and Prevention Program, Infectious Diseases Laboratories Division, Center for Laboratory Sciences, California Department of Public Health, Richmond, CA.

Jessica M Khouri (JM)

Infant Botulism Treatment and Prevention Program, Infectious Diseases Laboratories Division, Center for Laboratory Sciences, California Department of Public Health, Richmond, CA. Electronic address: jessica.khouri@cdph.ca.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH